SCHEMBL6681270

SCHEMBL6681270

CCc1cccc2[nH]c(CO)nc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.45
▸ DDAH1 O94760 1/20 0.42
▸ PARP1 P09874 2/20 0.41
▸ DAO P14920 2/20 0.40
▸ DDO Q99489 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HCAR2 Q8TDS4 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RHEB Q15382 1/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2899660 0.88 DDAH1 (0.55) CHEK1DDAH1DAODDOTDP1
SCHEMBL6582523 0.83 DDAH1 (0.42) CHEK1DDAH1DAODDOTDP1
SCHEMBL11498419 0.83 LIPG (0.40) CHEK1
SCHEMBL15767180 0.82 CHEK1 (0.41) CHEK1DDAH1PARP1HTR6KDM4E
SCHEMBL9589046 0.81 GRIN1 (0.49) CHEK1PARP1TDP1NPSR1RHEB
SCHEMBL3968950 0.80 DDAH1 (0.50) CHEK1DDAH1DAODDOALDH1A1
SCHEMBL8169941 0.80 POLB (0.46) PARP1
SCHEMBL4346855 0.79 MGAM (0.51) TDP1ALDH1A1
SCHEMBL15767459 0.78 CACNA1H (0.43) CHEK1PARP1ALDH1A1HTR6
SCHEMBL5788740 0.77 PARP1 (0.54) CHEK1DDAH1PARP1DAODDO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417182-A1 COMPOUNDS USEFUL FOR TREATMENT OR PREVENTION OF DISEASE MEDIATED BY ALPHA-2B-ADRENOCEPTOR Oy Juvantia Pharma Ltd (FI) 2004-05-12 — — EP disclosed
WO-2003008387-A1 COMPOUNDS USEFUL FOR TREATMENT OR PREVENTION OF DISEASE MEDIATED BY ALPHA-2B-ADRENOCEPTOR OY JUVANTIA PHARMA LTD (FI) 2003-01-30 — — WO disclosed
Send feedback